Shimadzu wins Frost & Sullivan’s Global General Radiography Product Line Strategy Leadership Award

NewsGuard 100/100 Score

Shimadzu Corporation was recognized for their global strategies and product launch efforts for diagnostic X-ray imaging systems and received the 2017 Global General Radiography Product Line Strategy Leadership Award from Frost & Sullivan, a major global market research and consulting company based in the U.S. The RADspeed Pro EDGE package general radiography system, the MobileDaRt Evolution MX7 version mobile X-ray system and the SONIALVISION G4 multi-functional universal R/F system, were the systems that determined the merit for this award.

The Global General Radiography Product Line Strategy Leadership Award was newly created in 2017 by Frost & Sullivan, a company that employs more than 1,800 consultants and industry analysts in offices located in more than 40 countries around the world. The award is presented to the company that introduces products and services that demonstrate the highest leadership in the global market for diagnostic X-ray imaging systems in 2016 and employs the best strategies for success.

Shimadzu, while continually designing systems and software to reduce X-ray exposure to patient and caregiver alike and while also improving the quality of images for diagnostic X-rays, was selected to be the first recipient of this award for the year 2016. Additionally, Shimadzu continues developing leading-edge applications supporting numerous types of examinations and diagnostic procedures. These measures and the company’s ability to penetrate the global market with high-performance diagnostic X-ray imaging systems, that meet all types of customer demands and combine versatility and functionality, were highly praised, resulting in the winning of this prestigious award.

“With our constant focus towards contributing to global healthcare, we are committed to offering the highest quality and most reliable products and services everywhere,” said Shimadzu.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses